Clinical trial
Early Feasibility Study of the MyoRegulator® for Treatment of ALS
NCT06165172 is registered in ClinicalTrials.gov with PathMaker Neurosystems Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Feasibility Study of the MyoRegulator® for Treatment of ALS
- Lead sponsor
- PathMaker Neurosystems Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 21, 2023
- Completion date
- August 31, 2024
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.